Skip to main content

Day: February 16, 2021

Rackspace Technology Named the CloudHealth Global Partner of the Year

SAN ANTONIO, Feb. 16, 2021 (GLOBE NEWSWIRE) —  Rackspace TechnologyTM (NASDAQ: RXT), a leading end-to-end, multicloud technology solutions company, announced today that it has been selected as the CloudHealth by VMware Global Partner of the Year.Partner of the Year winners are identified as standouts among hundreds of global cloud solution providers. The award places Rackspace Technology at the top of a group of top-level cloud MSPs experiencing rapid growth, while showcasing best practices in customer success. Awardees are recognized for their technical expertise, innovation and the great value they bring to our joint customers. Rackspace Technology recently received the honor during the 2021 CloudLIVE Solution Provider Virtual Summit.“We are proud to recognize Rackspace Technology as the 2020 CloudHealth Partner of the Year. Rackspace...

Continue reading

FOMO CORP. Acquires Assets of Independence LED Lighting

Chicago IL, Feb. 16, 2021 (GLOBE NEWSWIRE) — FOMO CORP., (US OTC: ETFM), has acquired the assets of Independence LED Lighting, LLC (“ILED”) for 250,000 restricted Series B Preferred shares valued at $2.5 million. As part of the transaction, FOMO incurs none of the ILED debt obligations.ILED, a U.S. manufacturer of energy-saving lighting, has a track record of quality installations that include marquis buildings such as Morgan Stanley’s Corporate Headquarters in New York City, MetLife’s offices across the U.S., and many small businesses. U.S Government “mission-critical” installations include over 30 U.S. Navy ships for Military Sealift Command, Marine Corps Base Quantico, the U.S. Department of Veterans Affairs Durham Medical Center, Walter Reed National Military Medical Center, and the Thumrait Air Base in Oman, among others.ILED...

Continue reading

Eramet: Good resilience of the Group in 2020, thanks to excellent operational performance and strong cash generation in the second half

Paris, 16 February 2021, 6:30 p.m.PRESS RELEASEEramet: Good resilience of the Group in 2020, thanks to excellent operational performance and strong cash generation in the second halfResponsible crisis management2020 targets achieved for the Mining and Metals division:5.8 Mt of manganese ore produced (+22% vs 2019), more than 6 Mt of transported ore (+30%) in Gabon2.5 Mwmt of nickel ore exports in New Caledonia (+55%)3.4 Mwmt of nickel ore and 23.5 kt-Ni of ferroalloys produced in IndonesiaCosts control in the High-Performance Alloys division in H21 in very deteriorated aerospace and automotive markets (A&D costs down -24% vs Q1 2020)EBITDA of €398m in 2020, with very strong growth in H2 (€278m) compared to H11 (€120m):Nearly +€250m in intrinsic gains over the year, mainly thanks to the increase in manganese sales volumes and nickel...

Continue reading

Eramet : Bonne résilience du Groupe en 2020, grâce à une excellente performance opérationnelle et une forte génération de cash au second semestre

Paris, le 16 février 2021, 18h30COMMUNIQUE DE PRESSEEramet : Bonne résilience du Groupe en 2020, grâce à une excellente performance opérationnelle et une forte génération de cash au second semestreGestion responsable de la criseAtteinte des objectifs 2020 de la division Mines et Métaux :5,8 Mt de production de minerai de manganèse (+22% par rapport à 2019), plus de 6 Mt de minerai transporté (+ 30 %) au Gabon2,5 Mth d’export de minerai de nickel en Nouvelle-Calédonie (+55%)3,4 Mth de production de minerai de nickel et 23,5 kt-Ni de ferroalliages en IndonésieMaitrise des coûts de la division Alliages Haute Performance au S21 dans des marchés aéronautique et automobile très dégradés (-24 % de coûts chez A&D par rapport au T1 2020)EBITDA de 398 M€ en 2020, avec une très forte progression au S2 (278 M€) par rapport au S11(120 M€) :Près...

Continue reading

Form 8.5 (EPT/RI) – Afh Financial Group Plc – Amendment

Amendment to Section 2(a)FORM 8.5 (EPT/RI)PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITYRule 8.5 of the Takeover Code (the “Code”)1.         KEY INFORMATION2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER(a)        Purchases and sales(b)        Derivatives transactions (other than options)(c)        Options transactions in respect of existing securities(i)         Writing, selling, purchasing or varying(ii)        Exercising(d)        Other dealings (including subscribing for new securities)The currency of all prices and other monetary amounts should be stated.Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of...

Continue reading

Access-Power & Co., Inc. is pleased to announce the Company TODAY has reaffirmed its commitment to our Securities Counsel, Steve Mills

GRAND HAVEN, Mich., Feb. 16, 2021 (GLOBE NEWSWIRE) — Access-Power & Co., Inc., (“ACCR or the Company”), a Grand Haven based diversified holding Company is pleased to announce the Company has affirmed its commitment to our new Securities Counsel, Steve Mills. Patrick J Jensen our Director said, “My shareholders and beloved Market Makers, ACCR is committed to Steve Mills. We just had a great phone call, and will be having another phone call tonight to analyze our Company share structure and valuation as a MERGER SHELL candidate.”Patrick continued, “ACCR is deal making. We want to assure that there is no assurance any deal can be reached. We talked about full cancellation of my current restricted shares, and rebuilding them with a re-filed FORM 10 soon, and re-issuance to the new MERGER candidate.”ACCR is a CLEAN SHELL with a DTC...

Continue reading

Anteris Technologies to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference

BRISBANE, Australia and EAGAN, Minn., Feb. 16, 2021 (GLOBE NEWSWIRE) — Anteris Technologies Ltd (ASX:AVR) (Anteris or the Company), a structural heart company advancing its novel DurAVR™ valve for aortic repair and replacement, today announced that Wayne Paterson, Chief Executive Officer, will present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Friday, February 19, 2021 at 10:30AM ET.About Anteris Technologies Ltd (ASX:AVR)Anteris Technologies Ltd is a structural heart company delivering clinically superior and durable solutions through better science and better design. Its focus is on developing next generation technologies that help healthcare professionals create life-changing outcomes for patients.The Anteris DurAVR™ aortic replacement valve addresses the acute need in terms of...

Continue reading

MICT Announces Closing of $60 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

MONTVALE, N.J., Feb. 16, 2021 (GLOBE NEWSWIRE) — MICT, Inc. (Nasdaq: MICT) (the “Company”), today announced that it closed its previously announced registered direct offering of (i) 22,471,904 shares of common stock, (ii) 22,471,904 Series A Warrants to purchase 22,471,904 shares of common stock and (iii) 11,235,952 Series B Warrants to purchase 11,235,952 shares of common stock at a combined purchase price of $2.67. The gross proceeds to MICT from this offering are approximately $60,000,000, before deducting placement agent fees and other estimated offering expenses. The Series A Warrants are exercisable six months after the date of issuance, have an exercise price of $2.80 per share and expire five and one-half years from the date of issuance. The Series B Warrants are exercisable six months after the date of issuance,...

Continue reading

Oliveda International, Inc. (OLVI) Subsidiary Products Gain Recognition by Top International Supermodel and Beauty Influencer

Santa Monica, CA, Feb. 16, 2021 (GLOBE NEWSWIRE) — Oliveda International, Inc. (OTC Pink: OLVI), a leading international natural cosmetics and wearable beauty and health technology innovator, is please to inform its shareholders that in a recent “Beauty Secrets” video for Vogue, which can been seen at https://www.vogue.com/article/gigi-hadid-beauty-secrets, international supermodel and beauty influencer Gigi Hadid revealed her use of multiple Oliveda products, which are produced by Oliveda International’s second-tier subsidiary. In the video, Ms. Hadid, who has almost 64 million Instagram followers, placing her in the top 40 most-followed Instagram accounts in the world (as of February 14, 2021), talks about some of her beauty secrets.  She states how she only wanted to use really clean and natural products for her skin during her...

Continue reading

AGTC to Present at the OIS Gene Therapy Innovation Showcase on February 18, 2021

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced that Sue Washer, President & Chief Executive Officer, will participate at the OIS Gene Therapy Innovation Showcase, taking place virtually on Thursday, February 18, 2021 from 12:00 PM to 3:00 PM CST.The event will include a market overview and start-up spotlight, followed by a panel discussion featuring recognized experts in the field. The panel will highlight unique perspectives on gene therapy in the eye care sector and product viability.Event registration is complimentary. To register, visit: https://hopin.com/sign_upAbout AGTCAGTC is...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.